Is GOVXW or STAG a better dividend investment in 2026?

GOVXW currently yields 57142.86% with a 5% 5-year dividend growth rate. STAG yields 3.44% with 1% growth. The better choice depends on your goal: GOVXW offers higher current income.

What is the dividend yield difference between GOVXW and STAG?

GOVXW has a forward dividend yield of 57142.86% ($2.00/share annually). STAG yields 3.44% ($1.24/share annually). The yield gap is 57139.42 percentage points.

Home › Compare › GOVXW vs STAG

GOVXW vs STAG: Dividend Comparison 2026

GOVXW yields 57142.86% · STAG yields 3.44%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GOVXW wins by $1.8137199447430393e+24M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GOVXW

● Live price

57142.86%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.8137199447430393e+24M

Annual income

$1,807,497,607,342,771,000,000,000,000,000.00

Full GOVXW calculator →

STAG

STAG Industrial Inc.

● Live price

3.44%

Share price

$36.06

Annual div

$1.24

5Y div CAGR

0.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$18.3K

Annual income

$462.70

Full STAG calculator →

Portfolio growth — GOVXW vs STAG

📍 GOVXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GOVXW	STAG
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GOVXW + STAG cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GOVXW pays

STAG pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GOVXW

Annual income on $10K today (after 15% tax)

$4,857,142.86/yr

After 10yr DRIP, annual income (after tax)

$1,536,372,966,241,355,200,000,000,000,000.00/yr

STAG

Annual income on $10K today (after 15% tax)

$292.69/yr

After 10yr DRIP, annual income (after tax)

$393.29/yr

At 15% tax rate, GOVXW beats the other by $1,536,372,966,241,355,200,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GOVXW + STAG for your $10,000?

GOVXW: 50%STAG: 50%

100% STAG50/50100% GOVXW

Portfolio after 10yr

$9.068599723715196e+23M

Annual income

$903,748,803,671,385,500,000,000,000,000.00/yr

Blended yield

99.66%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

GOVXW

No analyst data

Altman Z

-40.6

Piotroski

1/9

STAG

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$45.00

+24.8% upside vs current

Range: $39.00 — $59.00

Altman Z

1.2

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GOVXW buys

STAG buys

No recent congressional trades found for GOVXW or STAG in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGOVXWSTAG

Forward yield	57142.86% ✓	3.44%
Annual dividend / share	$2.00 ✓	$1.24
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0.3% ✓
Portfolio after 10y	$1.8137199447430393e+24M	$18.3K ✓
Annual income after 10y	$1,807,497,607,342,771,000,000,000,000,000.00 ✓	$462.70
Total dividends collected	$1.813311652454266e+24M	$4.0K ✓
Payment frequency	quarterly	monthly
Sector	Stock	REIT

Year-by-year: GOVXW vs STAG ($10,000, DRIP)

Year	GOVXW Portfolio	GOVXW Income/yr	STAG Portfolio	STAG Income/yr	Gap
1← crossover	$5,724,986	$5,714,285.71	$10,665	$345.38	+$5.71M → GOVXW
2	$3,063,527,985	$3,057,402,250.62	$11,365	$358.01	+$3063.52M → GOVXW
3	$1,532,308,824,967	$1,529,030,850,022.66	$12,099	$370.76	+$1532308.81M → GOVXW
4	$716,394,107,906,517	$714,754,537,463,802.60	$12,870	$383.63	+$716394107.89M → GOVXW
5	$313,071,475,901,711,400	$312,304,934,206,251,460.00	$13,678	$396.60	+$313071475901.70M → GOVXW
6	$127,886,778,198,343,160,000	$127,551,791,719,128,320,000.00	$14,526	$409.67	+$127886778198343.14M → GOVXW
7	$48,831,901,813,479,680,000,000	$48,695,062,960,807,450,000,000.00	$15,413	$422.82	+$48831901813479680.00M → GOVXW
8	$17,429,423,992,127,943,000,000,000	$17,377,173,857,187,520,000,000,000.00	$16,343	$436.05	+$17429423992127942656.00M → GOVXW
9	$5,815,268,598,381,736,000,000,000,000	$5,796,619,114,710,159,000,000,000,000.00	$17,315	$449.35	+$5.815268598381735e+21M → GOVXW
10	$1,813,719,944,743,039,200,000,000,000,000	$1,807,497,607,342,771,000,000,000,000,000.00	$18,332	$462.70	+$1.8137199447430393e+24M → GOVXW

GOVXW vs STAG: Complete Analysis 2026

GOVXW — Stock

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is also developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs, Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.

Full GOVXW Calculator →

STAG — REIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →

📬

Get this GOVXW vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GOVXW vs SCHD GOVXW vs JEPI GOVXW vs O GOVXW vs KO GOVXW vs MAIN GOVXW vs PLD GOVXW vs EQR GOVXW vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.